<p>资金雄厚的投资者对诺和诺德公司（Novo Nordisk NVO）采取了看涨的态度，这一点市场参与者不应忽视。我们在 Benzinga 跟踪公共期权记录时，今天揭示了这一重大举动。这些投资者的身份仍然未知，但 NVO 的如此大规模动作通常暗示着一些重大事件即将发生。</p>
<p>我们今天的观察中得知这一信息，当 Benzinga 的期权扫描仪突出了诺和诺德的 17 个异常期权活动时。这种活动水平非常不寻常。</p>
<p>这些重量级投资者的整体情绪分歧，52% 倾向于看涨，35% 看跌。在这些显著的期权中，有 9 个是看跌期权，总计 352,686 美元，8 个是看涨期权，总计 577,375 美元。</p>
<h3>价格目标是什么？</h3>
<p>分析这些合约的成交量和未平仓合约，似乎大玩家在过去一个季度内关注诺和诺德的价格区间为 75.0 美元到 155.0 美元。</p>
<h3>成交量与未平仓合约趋势</h3>
<p>查看成交量和未平仓合约是对股票进行尽职调查的一个有益方式。</p>
<p>这些数据可以帮助你跟踪诺和诺德在特定行权价的期权流动性和兴趣。</p>
<p>下面，我们可以观察到诺和诺德在过去 30 天内所有鲸鱼活动的看涨和看跌期权的成交量和未平仓合约的演变，行权价范围为 75.0 美元到 155.0 美元。</p>
<h3>诺和诺德过去 30 天的期权成交量和未平仓合约</h3>
<p><img src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2024/1734115610_0.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2024/1734115610_0.png"/></p>
<h3>值得注意的期权活动：</h3>
<table>
<thead>
<tr>
<th><strong>符号</strong></th>
<th><strong>看跌/看涨</strong></th>
<th><strong>交易类型</strong></th>
<th><strong>情绪</strong></th>
<th><strong>到期日</strong></th>
<th><strong>卖出价</strong></th>
<th><strong>买入价</strong></th>
<th><strong>价格</strong></th>
<th><strong>行权价</strong></th>
<th><strong>总交易价格</strong></th>
<th><strong>未平仓合约</strong></th>
<th><strong>成交量</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>NVO</td>
<td>看涨</td>
<td>交易</td>
<td>看涨</td>
<td>12/20/24</td>
<td>$3.35</td>
<td>$3.15</td>
<td>$3.7</td>
<td>$109.00</td>
<td>$185.0K</td>
<td>1.0K</td>
<td>554</td>
</tr>
<tr>
<td>NVO</td>
<td>看涨</td>
<td>扫描</td>
<td>看涨</td>
<td>01/17/25</td>
<td>$5.0</td>
<td>$4.8</td>
<td>$5.0</td>
<td>$110.00</td>
<td>$96.5K</td>
<td>3.9K</td>
<td>253</td>
</tr>
<tr>
<td>NVO</td>
<td>看涨</td>
<td>交易</td>
<td>中性</td>
<td>01/17/25</td>
<td>$19.0</td>
<td>$17.9</td>
<td>$18.4</td>
<td>$90.00</td>
<td>$91.9K</td>
<td>834</td>
<td>50</td>
</tr>
<tr>
<td>NVO</td>
<td>看跌</td>
<td>扫描</td>
<td>看跌</td>
<td>12/20/24</td>
<td>$3.2</td>
<td>$3.0</td>
<td>$3.2</td>
<td>$103.00</td>
<td>$72.9K</td>
<td>2.1K</td>
<td>778</td>
</tr>
<tr>
<td>NVO</td>
<td>看跌</td>
<td>扫描</td>
<td>看跌</td>
<td>01/03/25</td>
<td>$3.25</td>
<td>$3.05</td>
<td>$3.24</td>
<td>$100.00</td>
<td>$56.6K</td>
<td>342</td>
<td>211</td>
</tr>
</tbody>
</table>
<h3>关于诺和诺德</h3>
<p>诺和诺德在全球品牌糖尿病治疗市场中占据大约三分之一的份额，是全球领先的糖尿病护理产品提供商。该公司总部位于丹麦，生产和销售多种人用和现代胰岛素、GLP-1 疗法等注射糖尿病治疗药物、口服降糖药和肥胖治疗药物。诺和诺德还拥有一个生物制药部门（约占收入的 10%），专注于治疗血友病和其他疾病的蛋白质疗法。</p>
<p>在研究了诺和诺德的期权交易模式后，我们的注意力现在直接转向公司本身。这一转变使我们能够深入了解其当前的市场地位和表现。</p>
<h3>诺和诺德当前市场状态</h3>
<ul>
<li>交易量为 3,835,436，NVO 的价格下跌了-2.67%，目前为 105.72 美元。</li>
<li>RSI 指标显示该股票可能接近超买状态。</li>
<li>预计在 47 天内发布财报。</li>
</ul>
<p><strong>在短短 20 天内将 1000 美元变成 1270 美元？</strong></p>
<p>一位拥有 20 年经验的期权交易员揭示了他的单行图技术，显示何时买入和卖出。复制他的交易，平均每 20 天获得 27% 的利润。<strong>点击这里获取访问权限</strong>。</p>
<p>交易期权涉及更大的风险，但也提供了更高的利润潜力。精明的交易者通过持续教育、战略性交易调整、利用各种指标以及关注市场动态来降低这些风险。通过 Benzinga Pro 跟踪诺和诺德的最新期权交易，获取实时警报。</p>

诺和诺德公司

<p>资金雄厚的投资者对诺和诺德公司（Novo Nordisk, NVO）表现出乐观情绪，这从 Benzinga 跟踪的显著期权活动中可以看出。在这些显著的期权中，52% 是看涨期权，而 35% 是看跌期权，总共有 9 个看跌期权和 8 个看涨期权。NVO 的目标价格似乎在 100.00 美元到 110.00 美元之间。目前的交易量为 3,835,436，NVO 的价格下跌了 2.67%，报 105.72 美元。预计将在 47 天后发布财报</p>

<p>Deep-pocketed investors have adopted a bullish approach towards Novo Nordisk NVO, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in NVO usually suggests something big is about to happen.</p>
<div class="lb-trans"><p>资金雄厚的投资者对诺和诺德公司（Novo Nordisk NVO）采取了看涨的态度，这一点市场参与者不应忽视。我们在 Benzinga 跟踪公共期权记录时，今天揭示了这一重大举动。这些投资者的身份仍然未知，但 NVO 的如此大规模动作通常暗示着一些重大事件即将发生。</p>
</div><p>We gleaned this information from our observations today when Benzinga's options scanner highlighted 17 extraordinary options activities for Novo Nordisk. This level of activity is out of the ordinary.</p>
<div class="lb-trans"><p>我们今天的观察中得知这一信息，当 Benzinga 的期权扫描仪突出了诺和诺德的 17 个异常期权活动时。这种活动水平非常不寻常。</p>
</div><p>The general mood among these heavyweight investors is divided, with 52% leaning bullish and 35% bearish. Among these notable options, 9 are puts, totaling $352,686, and 8 are calls, amounting to $577,375.</p>
<div class="lb-trans"><p>这些重量级投资者的整体情绪分歧，52% 倾向于看涨，35% 看跌。在这些显著的期权中，有 9 个是看跌期权，总计 352,686 美元，8 个是看涨期权，总计 577,375 美元。</p>
</div><h3>What's The Price Target?</h3>
<div class="lb-trans"><h3>价格目标是什么？</h3>
</div><p>Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $75.0 to $155.0 for Novo Nordisk during the past quarter.</p>
<div class="lb-trans"><p>分析这些合约的成交量和未平仓合约，似乎大玩家在过去一个季度内关注诺和诺德的价格区间为 75.0 美元到 155.0 美元。</p>
</div><h3>Volume &amp; Open Interest Trends</h3>
<div class="lb-trans"><h3>成交量与未平仓合约趋势</h3>
</div><p>Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.</p>
<div class="lb-trans"><p>查看成交量和未平仓合约是对股票进行尽职调查的一个有益方式。</p>
</div><p>This data can help you track the liquidity and interest for Novo Nordisk's options for a given strike price.</p>
<div class="lb-trans"><p>这些数据可以帮助你跟踪诺和诺德在特定行权价的期权流动性和兴趣。</p>
</div><p>Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Novo Nordisk's whale activity within a strike price range from $75.0 to $155.0 in the last 30 days.</p>
<div class="lb-trans"><p>下面，我们可以观察到诺和诺德在过去 30 天内所有鲸鱼活动的看涨和看跌期权的成交量和未平仓合约的演变，行权价范围为 75.0 美元到 155.0 美元。</p>
</div><h3>Novo Nordisk Option Volume And Open Interest Over Last 30 Days</h3>
<div class="lb-trans"><h3>诺和诺德过去 30 天的期权成交量和未平仓合约</h3>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2024/1734115610_0.png" alt="" original-src="https://www.benzinga.com/files/images/story/2024/1734115610_0.png"/></p>
<h3>Noteworthy Options Activity:</h3>
<div class="lb-trans"><h3>值得注意的期权活动：</h3>
</div><table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>NVO</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$3.35</td>
<td>$3.15</td>
<td>$3.7</td>
<td>$109.00</td>
<td>$185.0K</td>
<td>1.0K</td>
<td>554</td>
</tr>
<tr>
<td>NVO</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$5.0</td>
<td>$4.8</td>
<td>$5.0</td>
<td>$110.00</td>
<td>$96.5K</td>
<td>3.9K</td>
<td>253</td>
</tr>
<tr>
<td>NVO</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/17/25</td>
<td>$19.0</td>
<td>$17.9</td>
<td>$18.4</td>
<td>$90.00</td>
<td>$91.9K</td>
<td>834</td>
<td>50</td>
</tr>
<tr>
<td>NVO</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$3.2</td>
<td>$3.0</td>
<td>$3.2</td>
<td>$103.00</td>
<td>$72.9K</td>
<td>2.1K</td>
<td>778</td>
</tr>
<tr>
<td>NVO</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/03/25</td>
<td>$3.25</td>
<td>$3.05</td>
<td>$3.24</td>
<td>$100.00</td>
<td>$56.6K</td>
<td>342</td>
<td>211</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th><strong>符号</strong></th>
<th><strong>看跌/看涨</strong></th>
<th><strong>交易类型</strong></th>
<th><strong>情绪</strong></th>
<th><strong>到期日</strong></th>
<th><strong>卖出价</strong></th>
<th><strong>买入价</strong></th>
<th><strong>价格</strong></th>
<th><strong>行权价</strong></th>
<th><strong>总交易价格</strong></th>
<th><strong>未平仓合约</strong></th>
<th><strong>成交量</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>NVO</td>
<td>看涨</td>
<td>交易</td>
<td>看涨</td>
<td>12/20/24</td>
<td>$3.35</td>
<td>$3.15</td>
<td>$3.7</td>
<td>$109.00</td>
<td>$185.0K</td>
<td>1.0K</td>
<td>554</td>
</tr>
<tr>
<td>NVO</td>
<td>看涨</td>
<td>扫描</td>
<td>看涨</td>
<td>01/17/25</td>
<td>$5.0</td>
<td>$4.8</td>
<td>$5.0</td>
<td>$110.00</td>
<td>$96.5K</td>
<td>3.9K</td>
<td>253</td>
</tr>
<tr>
<td>NVO</td>
<td>看涨</td>
<td>交易</td>
<td>中性</td>
<td>01/17/25</td>
<td>$19.0</td>
<td>$17.9</td>
<td>$18.4</td>
<td>$90.00</td>
<td>$91.9K</td>
<td>834</td>
<td>50</td>
</tr>
<tr>
<td>NVO</td>
<td>看跌</td>
<td>扫描</td>
<td>看跌</td>
<td>12/20/24</td>
<td>$3.2</td>
<td>$3.0</td>
<td>$3.2</td>
<td>$103.00</td>
<td>$72.9K</td>
<td>2.1K</td>
<td>778</td>
</tr>
<tr>
<td>NVO</td>
<td>看跌</td>
<td>扫描</td>
<td>看跌</td>
<td>01/03/25</td>
<td>$3.25</td>
<td>$3.05</td>
<td>$3.24</td>
<td>$100.00</td>
<td>$56.6K</td>
<td>342</td>
<td>211</td>
</tr>
</tbody>
</table>
</div><h3>About Novo Nordisk</h3>
<div class="lb-trans"><h3>关于诺和诺德</h3>
</div><p>With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting roughly 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.</p>
<div class="lb-trans"><p>诺和诺德在全球品牌糖尿病治疗市场中占据大约三分之一的份额，是全球领先的糖尿病护理产品提供商。该公司总部位于丹麦，生产和销售多种人用和现代胰岛素、GLP-1 疗法等注射糖尿病治疗药物、口服降糖药和肥胖治疗药物。诺和诺德还拥有一个生物制药部门（约占收入的 10%），专注于治疗血友病和其他疾病的蛋白质疗法。</p>
</div><p>Having examined the options trading patterns of Novo Nordisk, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance</p>
<div class="lb-trans"><p>在研究了诺和诺德的期权交易模式后，我们的注意力现在直接转向公司本身。这一转变使我们能够深入了解其当前的市场地位和表现。</p>
</div><h3>Novo Nordisk's Current Market Status</h3>
<div class="lb-trans"><h3>诺和诺德当前市场状态</h3>
</div><ul>
<li>Trading volume stands at 3,835,436, with NVO's price down by -2.67%, positioned at $105.72.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 47 days.</li>
</ul>
<div class="lb-trans"><ul>
<li>交易量为 3,835,436，NVO 的价格下跌了-2.67%，目前为 105.72 美元。</li>
<li>RSI 指标显示该股票可能接近超买状态。</li>
<li>预计在 47 天内发布财报。</li>
</ul>
</div><p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<div class="lb-trans"><p><strong>在短短 20 天内将 1000 美元变成 1270 美元？</strong></p>
</div><p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <strong>Click here for access</strong>.</p>
<div class="lb-trans"><p>一位拥有 20 年经验的期权交易员揭示了他的单行图技术，显示何时买入和卖出。复制他的交易，平均每 20 天获得 27% 的利润。<strong>点击这里获取访问权限</strong>。</p>
</div><p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Novo Nordisk with Benzinga Pro for real-time alerts.</p>
<div class="lb-trans"><p>交易期权涉及更大的风险，但也提供了更高的利润潜力。精明的交易者通过持续教育、战略性交易调整、利用各种指标以及关注市场动态来降低这些风险。通过 Benzinga Pro 跟踪诺和诺德的最新期权交易，获取实时警报。</p>
</div>

市场巨头及其最近对诺和诺德公司期权的投资